CLB Core Laboratories Inc

  1. Stocks
  2. Energy
  3. NYSE: CLB

Price (delayed)

$9.77

Market cap

$447.69M

P/E Ratio

28.74

Dividend/share

$0.04

EPS

$0.34

Enterprise value

$588.29M

?
Relative Growth: Rel. Growth: 28
Relative Strength: Rel. Strength: 20
Relative Valuation: Rel. Valuation: 60
Relative Profitability: Rel. Profitability: 38

Core Laboratories N.V. (Core Lab) is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. These products and services are directed toward ...

Highlights
CLB's debt is down by 3.1% YoY
CLB's equity is up by 2.4% YoY
The stock's price to earnings (P/E) is 23% less than its 5-year quarterly average of 39.0 but 18% more than its last 4 quarters average of 25.5
The quick ratio has decreased by 6% YoY but it has increased by 2.3% QoQ
CLB's net income has dropped by 52% year-on-year and by 36% since the previous quarter
Core Laboratories's EPS has plunged by 51% YoY and by 36% from the previous quarter
Sector: Energy
Industry: Oil & Gas Equipment & Services
Website: http://www.corelab.com
Peers: OII SLB FISV HAL

Key stats

What are the main financial stats of CLB

CLB stock price

How has the Core Laboratories stock price performed over time
Intraday
-4.12%
1 week
-5.42%
1 month
-1.51%
1 year
-39.5%
YTD
-39.05%
QTD
0.72%

Financial performance

How have Core Laboratories's revenue and profit performed over time
Revenue
$516.74M
Gross profit
$98.69M
Operating income
$38.94M
Net income
$15.56M
Gross margin
19.1%
Net margin
3%
CLB's net income has dropped by 52% year-on-year and by 36% since the previous quarter
CLB's net margin has plunged by 52% YoY and by 36% from the previous quarter
The operating margin has decreased by 29% YoY and by 18% from the previous quarter
Core Laboratories's operating income has decreased by 29% YoY and by 19% QoQ

Price vs fundamentals

How does CLB's price correlate with its fundamentals

Growth

What is Core Laboratories's growth rate over time

Valuation

What is Core Laboratories stock price valuation
CLB P/E details
P/E
28.74
P/B
1.61
P/S
0.87
EV/EBIT
15.14
EV/EBITDA
10.93
EV/Sales
1.14
Core Laboratories's EPS has plunged by 51% YoY and by 36% from the previous quarter
The stock's price to earnings (P/E) is 23% less than its 5-year quarterly average of 39.0 but 18% more than its last 4 quarters average of 25.5
The P/B is 58% below the 5-year quarterly average of 4.0 and 27% below the last 4 quarters average of 2.3
CLB's equity is up by 2.4% YoY
CLB's price to sales (P/S) is 47% lower than its 5-year quarterly average of 1.7 and 25% lower than its last 4 quarters average of 1.2

Efficiency

How efficient is Core Laboratories business performance
The return on equity has dropped by 54% year-on-year and by 37% since the previous quarter
The ROA has plunged by 52% YoY and by 37% from the previous quarter
Core Laboratories's ROS has decreased by 29% YoY and by 18% from the previous quarter
The return on invested capital has declined by 25% year-on-year and by 17% since the previous quarter

Dividends

What is CLB's dividend history
Dividend details
DPS
$0.04
Dividend yield
0.41%
Payout ratio
11.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Core Laboratories financials performed over time
The total assets is 92% greater than the total liabilities
CLB's current ratio is down by 8% year-on-year but it is up by 3.3% since the previous quarter
The quick ratio has decreased by 6% YoY but it has increased by 2.3% QoQ
CLB's debt is 42% less than its equity
The debt to equity has decreased by 6% YoY and by 4.9% QoQ
CLB's debt is down by 3.1% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.